“Low Dose (d1-5 7) Oral Etoposide Regimen in Intensively Treated Platinum-Resistant Epithelial Ovarian Cancer: The İzmir Oncology Group (IZOG) Study ”. Annals of Medical Research 27, no. 1 (May 25, 2021): 0029–0033. Accessed April 4, 2025. http://annalsmedres.org/index.php/aomr/article/view/591.